Clinical Pharmacist and Master’s student in Clinical Pharmacy with research interests in pharmacovigilance, behavioral interventions in mental health, and AI applications in clinical decision support. Experience includes digital health research with Bloomsbury Health (London) and pharmacovigilance practice in patient support programs. Published work covers drug awareness among healthcare providers, postpartum depression management, and patient safety reporting. 
Clinical Pharmacist and Master’s student in Clinical Pharmacy with research interests in pharmacovigilance, behavioral interventions in mental health, and AI applications in clinical decision support. Experience includes digital health research with Bloomsbury Health (London) and pharmacovigilance practice in patient support programs. Published work covers drug awareness among healthcare providers, postpartum depression management, and patient safety reporting. What was reviewed
This Environmental Health Perspectives news feature reviewed the evidence base and policy tradeoffs shaping inorganic arsenic in rice regulation, focusing on how regulators choose “just right” maximum levels that reduce long-term dietary exposure while remaining feasible for producers to meet and for agencies to enforce. It synthesizes why rice is a priority exposure source, noting rice can absorb far more arsenic from soil than other grains and that rice ingredients (flour, syrup) extend exposure into processed foods, including infant and toddler products. The article then maps the regulatory landscape and scientific uncertainties that complicate standard setting, including debate over whether inorganic arsenic should be treated as a nonthreshold carcinogen (any dose carries some cancer risk) or whether a threshold exists at low dose. It reviews competing benchmark values proposed or discussed by Codex Alimentarius and advocates, the sampling datasets used to justify feasibility-based limits, and the practical constraints of monitoring a contaminant that varies by geography, cultivar, and processing.
Who was reviewed
Rather than enrolling participants, the piece reviewed multiple stakeholder and evidence streams relevant to inorganic arsenic in rice regulation. It foregrounds high-consumption and higher-susceptibility groups that policy must protect, including “virtually all children,” people living in South Asia, and individuals consuming more rice due to dietary needs such as gluten intolerance. It also reviewed epidemiologic and toxicologic findings referenced by interviewed experts, including evidence connecting arsenic exposure with cardiovascular, lung, and cognitive outcomes and observations that children may be uniquely sensitive to low-dose exposures, with fetal exposure linked to infections and diarrhea in early life. On the policy side, it reviewed positions and data from regulators and standard setters (FDA, EPA, WHO, Codex), consumer-testing and advocacy groups (Consumer Reports/Consumers Union), and industry representatives (USA Rice Federation), illustrating how feasibility, enforceability, and health-protective intent are weighed differently across constituencies.
Most important findings
For HMTC-aligned decision-making, the article’s core contribution is clarifying how enforceable food standards for inorganic arsenic are commonly anchored to feasibility data (sampling distributions and exceedance rates) and then contested using alternative risk-assessment assumptions, especially for infant-targeted products.
| Critical point | Details |
|---|---|
| Rice as a distinctive dietary arsenic source | Rice is highlighted as unusually efficient at arsenic uptake, with exposures amplified by rice-derived ingredients (flour, syrup) in processed foods, including baby foods, expanding the certification-relevant product universe beyond whole grain. |
| Toxicity depends on speciation and context | The piece stresses that inorganic arsenic is more toxic than organic forms and that dietary risk is harder to quantify than water exposure because absorption varies by food matrix; it also notes nutrients in rice (e.g., B vitamins, selenium) may mitigate toxicity, complicating simplistic “total arsenic” interpretations for certification thresholds. |
| Codex feasibility-based maximum for white rice | Codex proposed 0.2 mg/kg inorganic arsenic for white/polished rice; selection was tied to sampling from multiple regions and a low exceedance rate (2%), explicitly framed as “as low as reasonably achievable,” emphasizing enforceability as a nonnegotiable requirement. |
| Higher-risk product categories and data gaps | Brown rice typically shows higher arsenic because arsenic concentrates in the outer layer removed during polishing; Codex discussions on a brown rice limit (e.g., 0.4 mg/kg proposal) stalled due to insufficient global occurrence data, signaling where HMTC may need stronger surveillance expectations. |
| U.S. marketplace test data suggest achievability but not “safety” | Consumer Reports testing of 223 products found nearly all below 0.2 mg/kg, and FDA analysis of >1,300 samples concluded levels were too low for immediate/short-term effects, while explicitly flagging the need to learn more about long-term low-dose impacts—an evidence posture that fits certification’s preventive intent. |
| Competing proposals for stricter limits, especially for infants | Critics argue 0.2 mg/kg is not health-risk-assessment based; proposals include 0.12 mg/kg for white and brown rice (Consumers Union) and 0.1 mg/kg for all rice products with 0.05 mg/kg for infant/young-child products (Meharg), with feasibility claims that large shares of U.S. rice could meet 0.12 mg/kg. |
| Mitigation pathways extend beyond limits | The article reviews mitigation options relevant to certification continuous improvement, including cultivar selection/breeding for lower uptake and emerging microbial or genetic approaches; it also reflects stakeholder concerns that some technologies (e.g., genetic engineering) may face consumer resistance, affecting practical adoption. |
Key implications
For inorganic arsenic in rice regulation, the primary regulatory impacts center on moving from advisory language to enforceable, speciation-based maximum levels supported by occurrence data and clear compliance pathways. HMTC certification requirements should therefore mandate inorganic-arsenic speciation testing, risk-tiered limits for infant/young-child rice ingredients, and documented supplier controls that address cultivar/origin variability. Industry applications include preferential sourcing from lower-arsenic regions and product reformulation to reduce rice-based sweeteners. Research gaps persist around long-term low-dose dietary outcomes and globally representative brown-rice data; practical recommendations include setting an HMTC action level tighter than 0.2 mg/kg for high-exposure products while using feasibility audits to maintain enforceability.
Citation
Schmidt CW. In Search of “Just Right”: The Challenge of Regulating Arsenic in Rice. Environmental Health Perspectives. 2015;123(1):A16-A19. doi:10.1289/ehp.123-A16
Arsenic is a naturally occurring metalloid that ranks first on the ATSDR toxic substances list. Inorganic arsenic contaminates water, rice and consumer products, and exposure is linked to cardiovascular disease, cognitive deficits, low birth weight and cancer. HMTC’s stringent certification applies ALARA principles to protect vulnerable populations.
